Responses
Renal medicine
Protocol
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.